|
|
Volumn 71, Issue 7, 1996, Pages 659-670
|
|
Treatment of early Parkinson's disease: Are complicated strategies justified?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE;
AMANTADINE;
AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B;
BENSERAZIDE PLUS LEVODOPA;
BENZATROPINE MESILATE;
BROMOCRIPTINE;
BROMOCRIPTINE MESILATE;
CARBIDOPA;
CARBIDOPA PLUS LEVODOPA;
CHOLINERGIC RECEPTOR BLOCKING AGENT;
DOMPERIDONE;
DOPAMINE;
LEVODOPA;
PERGOLIDE;
PERGOLIDE MESILATE;
PROCYCLIDINE;
SELEGILINE;
TRIHEXYPHENIDYL;
TRIMETHOBENZAMIDE;
CLINICAL TRIAL;
CONTROLLED RELEASE FORMULATION;
DISEASE COURSE;
DYSKINESIA;
HUMAN;
MORTALITY;
NAUSEA;
NEUROPROTECTION;
NONHUMAN;
OXIDATIVE STRESS;
PARKINSON DISEASE;
REVIEW;
|
|
EID: 0030317103
PISSN: 00256196
EISSN: None
Source Type: Journal
DOI: 10.1016/S0025-6196(11)63004-8 Document Type: Review |
|
Times cited : (21)
|
|
References (90)
|
